ANG Lifesciences India Ltd (ANG) is currently trading at 35.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

ANG Lifesciences India Limited specializes in manufacturing and marketing sterile dry powder injection vials, primarily targeting hospitals and doctors through stockists. The company operates four formulation plants in Baddi, Himachal Pradesh, equipped with advanced technology for producing Beta Lactum and Non-Beta Lactum products. ANG Lifesciences has expanded its geographical presence into India, Africa, Gulf countries, and ROW countries, reflecting a growing international footprint. The acquisition of Mansa Printers & Publishers Limited in April 2021 marks a strategic move for cost optimization in pharma packaging through backward integration. Compliance with GMP requirements and ISO 9001:2008 certification underscores the company's commitment to quality and operational excellence.

Over the past 52 weeks, ANG Lifesciences India Ltd has traded between a low of ₹17.63 and a high of ₹49.69. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

ANG Lifesciences India Ltd has a market capitalization of approximately 45.83. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

ANG Lifesciences India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -3.44 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 45.83 Cr, ANG Lifesciences India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

ANG Lifesciences India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of ANG Lifesciences India Ltd is -3.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.